{"bekendtgoerelseNoegle":{"noticeId":{"value":"d65e9eb6-e0a7-4316-97cf-db427c503ba0"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00699614-2024"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: Statens Serum Institut
\n
Køberens retlige status: Offentligretligt organ, der styres af en central regeringsmyndighed
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
\n
Beskrivelse: The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines\n in the event of an influenza pandemic during the contract period. The contract (advance\n purchase agreement) regards reservation of the supplier’s production capacity and\n the contract will contain an option for purchase of pandemic influenza vaccine in\n the event of an influenza pandemic called by the WHO during the contract period. The\n reserved volume of pandemic vaccine is expected to be 7.6 million doses; however,\n the number of doses may be reduced by SSI as described in the tender documents. SSI\n expects that the Agreement cannot be awarded without prior negotiations with potential\n suppliers due to the specific circumstances related to the nature and the complexity\n of the Agreement and the legal and financial aspects and the associated risks. In\n essence, the procedure encompasses a complex advance purchase agreement, and SSI is\n dependent on further information from potential suppliers in order to establish a\n complete and adequate set of terms and conditions in accordance with what the market\n operators are able to meet. This makes it necessary for SSI to be able to negotiate\n various as-pects of both the tender documents and the tenders received and potentially\n make various changes to the tender documents. Hence, the procurement will be conducted\n as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All\n terms and requirements that are not minimum requirements may be subject to negotiation\n and may be changed or withdrawn during the tender procedure according to SSI’s decision.\n Thus, SSI encourages all economic operators who comply with the minimum requirements\n (stated in the Tender Specification, paragraph 5) to apply for prequalification, even\n if the economic operator cannot comply with other terms and requirements.
\n
Identifikator for proceduren: 8ed75d6b-04fe-446e-8ba8-0c9dd0bee67c
\n
Tidligere bekendtgørelse: 991da097-b923-4f9e-8a5b-997bd5d5fdd9-01
\n
Intern identifikator: 4033881
\n
Udbudsprocedure: Udbud med forhandling/indkaldelse af tilbud med forudgående offentliggørelse
\n
Proceduren er en hasteprocedure: nej
\n
Hovedpunkterne i proceduren: After receipt of Indicative Offers (INDO1), SSI will conduct individual negotiation\n meetings with all tenderers who have submitted an INDO within the deadline stated.\n The negotiations will be conducted in accordance with the principle of equal treatment,\n and all tenderers will be given the same amount of time for negotiations with SSI.\n After the negotiations, SSI may choose to issue revised tender documents for further\n Indicative Offers or Best and Final Offer (BAFO). The tenderers will be informed thereof\n at the same time with an invitation to submit an INDO or BAFO. SSI will not pay a\n participation fee to the tenderers. For further information on the process of the\n negotiations, reference is made to the tender specifications, paragraph 11.
\n
2.1.1 Formål
Kontraktens art: Varer
\n
Primær klassificering (cpv): 33651600 Vacciner
\n
\n
2.1.2 Udførelsessted
Postadresse: Artellerivej 5  
\n
By: København S
\n
Postnummer: 2300
\n
Landespecifik underafdeling (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
\n
2.1.4 Generelle oplysninger
Yderligere oplysninger: The price is confidential which is also reflected in the contract value of DKK 1.
\n
Retsgrundlag:
\n
Direktiv 2014/24/EU
\n
http://data.europa.eu/eli/dir/2014/24/oj - Directive 2014/24/EU.
\n
https://www.retsinformation.dk/eli/lta/2015/1564 - The tender procedure is covered by the Danish Public Procurement Act (Act No. 1564\n of 15 December 2015 as amended), which implements the Public Procurement Directive\n (Directive 2014/24/EU).
\n
\n
\n
\n
5 Delkontrakt
5.1 Teknisk ID for partiet: LOT-0000
Titel: Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
\n
Beskrivelse: The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines\n in the event of an influenza pandemic during the contract period. The contract (advance\n purchase agreement) regards reservation of the supplier’s production capacity and\n the contract will contain an option for purchase of pandemic influenza vaccine in\n the event of an influenza pandemic called by the WHO during the contract period. The\n reserved volume of pandemic vaccine is expected to be 7.6 million doses; however,\n the number of doses may be reduced by SSI as described in the tender documents. SSI\n expects that the Agreement cannot be awarded without prior negotiations with potential\n suppliers due to the specific circumstances related to the nature and the complexity\n of the Agreement and the legal and financial aspects and the associated risks. In\n essence, the procedure encompasses a complex advance purchase agreement, and SSI is\n dependent on further information from potential suppliers in order to establish a\n complete and adequate set of terms and conditions in accordance with what the market\n operators are able to meet. This makes it necessary for SSI to be able to negotiate\n various as-pects of both the tender documents and the tenders received and potentially\n make various changes to the tender documents. Hence, the procurement will be conducted\n as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All\n terms and requirements that are not minimum requirements may be subject to negotiation\n and may be changed or withdrawn during the tender procedure according to SSI’s decision.\n Thus, SSI encourages all economic operators who comply with the minimum requirements\n (stated in the Tender Specification, paragraph 5) to apply for prequalification, even\n if the economic operator cannot comply with other terms and requirements.
\n
Intern identifikator: 4033881
\n
5.1.1 Formål
Kontraktens art: Varer
\n
Primær klassificering (cpv): 33651600 Vacciner
\n
\n
5.1.2 Udførelsessted
Postadresse: Artellerivej 5  
\n
By: København S
\n
Postnummer: 2300
\n
Landespecifik underafdeling (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Yderligere oplysninger: 
\n
\n
5.1.3 Anslået varighed
Varighed: 24 Måned
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 3
\n
Køberen forbeholder sig retten til at foretage yderligere indkøb fra entreprenøren som beskrevet her: The duration of 24 months is including potential extensions of the Agreement. The\n Initial Term of the Agreement is from the signature of the Agreement (expected to\n be 1 November 2024) until 31 March 2025. SSI is entitled to extend the term of the\n agreement one or more times up to a total duration of 24 months.
\n
\n
5.1.6 Generelle oplysninger
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
Yderligere oplysninger: The price is confidential which is also reflected in the contract value of DKK 1.
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Pris
\n
Navn: Price
\n
Beskrivelse: Reference is made to the Tender Specifications, Appendix A, section 1.1.
\n
Vægtning (procentdel, præcis): 50
\n
\n
Kriterium:
Type: Kvalitet
\n
Navn: Delivery
\n
Beskrivelse: Reference is made to the Tender Specifications, Appendix A, section 1.2.
\n
Vægtning (procentdel, præcis): 20
\n
\n
Kriterium:
Type: Kvalitet
\n
Navn: Liability
\n
Beskrivelse: Reference is made to the Tender Specifications, Appendix A, section 1.3.
\n
Vægtning (procentdel, præcis): 15
\n
\n
Kriterium:
Type: Kvalitet
\n
Navn: Flexibility
\n
Beskrivelse: Reference is made to the Tender Specifications, Appendix A, section 1.4.
\n
Vægtning (procentdel, præcis): 15
\n
\n
\n
5.1.12 Udbudsvilkår
Oplysninger om undersøgelsesfrister: Pursuant to the Danish Act on the Complaints Board for Public Procurement, etc. (lov\n om Klagenævnet for Udbud m.v.) (the Act is available (in Danish) at www.retsinformation.dk),\n the following deadlines apply to the lodging of complaints: Complaints of not having\n been selected must be submitted to the Danish Complaints Board for Public Procurement\n before the expiry of 20 calendar days, see section 7(1) of the Act, from the day after\n submission of notification to the candidates concerned of the identity of the successful\n tenderer where the notification is accompanied by an explanation of the grounds for\n the decision in accordance with section 2(1), para (1) of the Act and section 171(2)\n of the Danish Public Procurement Act. In other situations, complaints of award procedures,\n see section 7(2) of the Act, must be lodged with the Danish Complaints Board for Public\n Procurement before the expiry of: 45 calendar days after the contracting entity has\n published a notice in the Official Journal of the European Union that the contracting\n entity has entered into a contract. The deadline is calculated from the day after\n the day when the notice was published. Not later than at the time of lodging a complaint\n with the Danish Complaints Board for Public Procurement, the complainant must notify\n the contracting entity in writing that a complaint has been lodged with the Danish\n Complaints Board for Public Procurement and whether the complaint was lodged during\n the standstill period, see section 6(4) of the Act. In cases where the complaint was\n not lodged within the standstill period, the complainant must furthermore indicate\n whether a suspensory effect of the complaint has been requested, see section 12(1)\n of the Act. The e-mail address of the Complaints Board for Public Procurement is klfu@naevneneshus.dk.\n The Complaints Board’s own complaints procedure is available at https://naevneneshus.dk/start-din-klage/klagenaevnet-for-udbud/vejledning/.
\n
\n
5.1.15 Teknikker
Rammeaftale:
Ingen rammeaftale
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for Udbud
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
TED eSender: Mercell Holding ASA
\n
\n
\n
\n
6 Resultater
Værdien af alle kontrakter tildelt i denne meddelelse: 1 Dansk krone
\n
6.1 Resultat delkontrakt-ID: LOT-0000
Der er udvalgt mindst én vinder.
\n
6.1.2 Oplysninger om vinderne
Vinder:
Officielt navn: Seqirus UK Limited
\n
Tilbud:
\n
Tilbud – Identifikator: Advance purchase agreement - Seqirus UK Limited
\n
Identifikator for delkontrakt eller gruppe af delkontrakter: LOT-0000
\n
Underentreprise: Ja
\n
Underentrepriseværdien er kendt: nej
\n
Underentrepriseprocentdelen er kendt: nej
\n
Beskrivelse: Seqirus Vaccines Limited, Seqirus BV, Seqirus srl and Rovi Contract Manufacturing\n S.L.
\n
Kontraktoplysninger:
Identifikator for kontrakten: Advance Purchase Agreement - Seqirus UK Limited
\n
Dato for indgåelse af kontrakten: 16-10-2024
\n
Kontrakten tildeles som led i en rammeaftale: nej
\n
\n
\n
\n
6.1.4 Statistiske oplysninger
Modtagne tilbud og ansøgninger om deltagelse:
Type modtagne indgivelser: Tilbud
Antal modtagne tilbud og ansøgninger om deltagelse: 1
\n
\n
Type modtagne indgivelser: Tilbud, der er indgivet ad elektronisk vej
Antal modtagne tilbud og ansøgninger om deltagelse: 1
\n
\n
Type modtagne indgivelser: Tilbud fra mikrovirksomheder samt små eller mellemstore virksomheder
Antal modtagne tilbud og ansøgninger om deltagelse: 0
\n
\n
Type modtagne indgivelser: Tilbud fra tilbudsgivere, der er registreret i andre EØS-lande end købers land
Antal modtagne tilbud og ansøgninger om deltagelse: 0
\n
\n
Type modtagne indgivelser: Tilbud fra tilbudsgivere, der er registreret i lande uden for EØS
Antal modtagne tilbud og ansøgninger om deltagelse: 1
\n
\n
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: Statens Serum Institut
\n
Registreringsnummer: 46 83 74 28
\n
Postadresse: Artillerivej 5  
\n
By: København S
\n
Postnummer: 2300
\n
Landespecifik underafdeling (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
E-mail: nea@ssi.dk
\n
Telefon: +4532683978
\n
Internetadresse: https://www.ssi.dk
\n
Køberprofil: https://eu.eu-supply.com/ctm/company/companyinformation/index/281426
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0002
Officielt navn: Klagenævnet for Udbud
\n
Registreringsnummer: 37795526
\n
Postadresse: Nævnenes Hus, Toldboden 2  
\n
By: Viborg
\n
Postnummer: 8800
\n
Landespecifik underafdeling (NUTS): Vestjylland (DK041)
\n
Land: Danmark
\n
E-mail: klfu@naevneneshus.dk
\n
Telefon: +45 72405600
\n
Internetadresse: https://klfu.naevneneshus.dk/
\n
Denne organisations roller:
Organisation med ansvar for klager
\n
\n
\n
8.1 ORG-0003
Officielt navn: Konkurrence- og Forbrugerstyrelsen
\n
Registreringsnummer: 10294819
\n
Postadresse: Carl Jacobsens Vej 35  
\n
By: Valby
\n
Postnummer: 2500
\n
Landespecifik underafdeling (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
E-mail: kfst@kfst.dk
\n
Telefon: +45 41715000
\n
Internetadresse: http://www.kfst.dk
\n
Denne organisations roller:
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
\n
\n
8.1 ORG-0004
Officielt navn: Seqirus UK Limited
\n
Registreringsnummer: GB685546196
\n
Postadresse: Point, 29 Market Street  
\n
By: Maidenhead
\n
Postnummer: SL6 8AA
\n
Landespecifik underafdeling (NUTS): Berkshire (UKJ11)
\n
Land: Det Forenede Kongerige
\n
E-mail: adam.lewington1@seqirus.com
\n
Telefon: +44 (0)7584 388775
\n
Internetadresse: https://www.csl.com/wearecsl/ourbusinessesandproducts/cslseqirus
\n
Denne organisations roller:
Tilbudsgiver
\n
Vinder af disse delkontrakter: LOT-0000
\n
\n
\n
8.1 ORG-0005
Officielt navn: Mercell Holding ASA
\n
Registreringsnummer: 980921565
\n
Postadresse: Askekroken 11  
\n
By: Oslo
\n
Postnummer: 0277
\n
Landespecifik underafdeling (NUTS): Oslo (NO081)
\n
Land: Norge
\n
Kontaktpunkt: eSender
\n
E-mail: publication@mercell.com
\n
Telefon: +47 21018800
\n
Fax: +47 21018801
\n
Internetadresse: http://mercell.com/
\n
Denne organisations roller:
TED eSender
\n
\n
\n
\n
11 Oplysninger om bekendtgørelsen
11.1 Oplysninger om bekendtgørelsen
Identifikator for bekendtgørelsen: d65e9eb6-e0a7-4316-97cf-db427c503ba0 - 01
\n
Formulartype: Resultater
\n
Bekendtgørelsestype: Bekendtgørelse om indgåede kontrakter eller koncessionstildeling – standardordningen
\n
Afsendelsesdato for bekendtgørelsen: 14-11-2024 16:32 +00:00
\n
Dato for afsendelse af bekendtgørelse (eSender): 14-11-2024 17:00 +00:00
\n
Sprog, som denne bekendtgørelse er officielt tilgængelig på: engelsk 
\n
\n
11.2 Oplysninger om offentliggørelsen
Bekendtgørelsesnummer: 00699614-2024
\n
EUT-S-nummer: 224/2024
\n
Offentliggørelsesdato: 18-11-2024
\n
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: Statens Serum Institut
\n
Legal type of the buyer: Body governed by public law, controlled by a central government authority
\n
Activity of the contracting authority: Health
\n
\n
\n
2 Procedure
2.1 Procedure
Title: Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
\n
Description: The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines\n in the event of an influenza pandemic during the contract period. The contract (advance\n purchase agreement) regards reservation of the supplier’s production capacity and\n the contract will contain an option for purchase of pandemic influenza vaccine in\n the event of an influenza pandemic called by the WHO during the contract period. The\n reserved volume of pandemic vaccine is expected to be 7.6 million doses; however,\n the number of doses may be reduced by SSI as described in the tender documents. SSI\n expects that the Agreement cannot be awarded without prior negotiations with potential\n suppliers due to the specific circumstances related to the nature and the complexity\n of the Agreement and the legal and financial aspects and the associated risks. In\n essence, the procedure encompasses a complex advance purchase agreement, and SSI is\n dependent on further information from potential suppliers in order to establish a\n complete and adequate set of terms and conditions in accordance with what the market\n operators are able to meet. This makes it necessary for SSI to be able to negotiate\n various as-pects of both the tender documents and the tenders received and potentially\n make various changes to the tender documents. Hence, the procurement will be conducted\n as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All\n terms and requirements that are not minimum requirements may be subject to negotiation\n and may be changed or withdrawn during the tender procedure according to SSI’s decision.\n Thus, SSI encourages all economic operators who comply with the minimum requirements\n (stated in the Tender Specification, paragraph 5) to apply for prequalification, even\n if the economic operator cannot comply with other terms and requirements.
\n
Procedure identifier: 8ed75d6b-04fe-446e-8ba8-0c9dd0bee67c
\n
Previous notice: 991da097-b923-4f9e-8a5b-997bd5d5fdd9-01
\n
Internal identifier: 4033881
\n
Type of procedure: Negotiated with prior publication of a call for competition / competitive with negotiation
\n
The procedure is accelerated: no
\n
Main features of the procedure: After receipt of Indicative Offers (INDO1), SSI will conduct individual negotiation\n meetings with all tenderers who have submitted an INDO within the deadline stated.\n The negotiations will be conducted in accordance with the principle of equal treatment,\n and all tenderers will be given the same amount of time for negotiations with SSI.\n After the negotiations, SSI may choose to issue revised tender documents for further\n Indicative Offers or Best and Final Offer (BAFO). The tenderers will be informed thereof\n at the same time with an invitation to submit an INDO or BAFO. SSI will not pay a\n participation fee to the tenderers. For further information on the process of the\n negotiations, reference is made to the tender specifications, paragraph 11.
\n
2.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33651600 Vaccines
\n
\n
2.1.2 Place of performance
Postal address: Artellerivej 5  
\n
Town: København S
\n
Postcode: 2300
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
\n
2.1.4 General information
Additional information: The price is confidential which is also reflected in the contract value of DKK 1.
\n
Legal basis:
\n
Directive 2014/24/EU
\n
http://data.europa.eu/eli/dir/2014/24/oj - Directive 2014/24/EU.
\n
https://www.retsinformation.dk/eli/lta/2015/1564 - The tender procedure is covered by the Danish Public Procurement Act (Act No. 1564\n of 15 December 2015 as amended), which implements the Public Procurement Directive\n (Directive 2014/24/EU).
\n
\n
\n
\n
5 Lot
5.1 Lot technical ID: LOT-0000
Title: Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
\n
Description: The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines\n in the event of an influenza pandemic during the contract period. The contract (advance\n purchase agreement) regards reservation of the supplier’s production capacity and\n the contract will contain an option for purchase of pandemic influenza vaccine in\n the event of an influenza pandemic called by the WHO during the contract period. The\n reserved volume of pandemic vaccine is expected to be 7.6 million doses; however,\n the number of doses may be reduced by SSI as described in the tender documents. SSI\n expects that the Agreement cannot be awarded without prior negotiations with potential\n suppliers due to the specific circumstances related to the nature and the complexity\n of the Agreement and the legal and financial aspects and the associated risks. In\n essence, the procedure encompasses a complex advance purchase agreement, and SSI is\n dependent on further information from potential suppliers in order to establish a\n complete and adequate set of terms and conditions in accordance with what the market\n operators are able to meet. This makes it necessary for SSI to be able to negotiate\n various as-pects of both the tender documents and the tenders received and potentially\n make various changes to the tender documents. Hence, the procurement will be conducted\n as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All\n terms and requirements that are not minimum requirements may be subject to negotiation\n and may be changed or withdrawn during the tender procedure according to SSI’s decision.\n Thus, SSI encourages all economic operators who comply with the minimum requirements\n (stated in the Tender Specification, paragraph 5) to apply for prequalification, even\n if the economic operator cannot comply with other terms and requirements.
\n
Internal identifier: 4033881
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 33651600 Vaccines
\n
\n
5.1.2 Place of performance
Postal address: Artellerivej 5  
\n
Town: København S
\n
Postcode: 2300
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Additional information: 
\n
\n
5.1.3 Estimated duration
Duration: 24 Month
\n
\n
5.1.4 Renewal
Maximum renewals: 3
\n
The buyer reserves the right for additional purchases from the contractor, as described here: The duration of 24 months is including potential extensions of the Agreement. The\n Initial Term of the Agreement is from the signature of the Agreement (expected to\n be 1 November 2024) until 31 March 2025. SSI is entitled to extend the term of the\n agreement one or more times up to a total duration of 24 months.
\n
\n
5.1.6 General information
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
Additional information: The price is confidential which is also reflected in the contract value of DKK 1.
\n
\n
5.1.10 Award criteria
Criterion:
Type: Price
\n
Name: Price
\n
Description: Reference is made to the Tender Specifications, Appendix A, section 1.1.
\n
Weight (percentage, exact): 50
\n
\n
Criterion:
Type: Quality
\n
Name: Delivery
\n
Description: Reference is made to the Tender Specifications, Appendix A, section 1.2.
\n
Weight (percentage, exact): 20
\n
\n
Criterion:
Type: Quality
\n
Name: Liability
\n
Description: Reference is made to the Tender Specifications, Appendix A, section 1.3.
\n
Weight (percentage, exact): 15
\n
\n
Criterion:
Type: Quality
\n
Name: Flexibility
\n
Description: Reference is made to the Tender Specifications, Appendix A, section 1.4.
\n
Weight (percentage, exact): 15
\n
\n
\n
5.1.12 Terms of procurement
Information about review deadlines: Pursuant to the Danish Act on the Complaints Board for Public Procurement, etc. (lov\n om Klagenævnet for Udbud m.v.) (the Act is available (in Danish) at www.retsinformation.dk),\n the following deadlines apply to the lodging of complaints: Complaints of not having\n been selected must be submitted to the Danish Complaints Board for Public Procurement\n before the expiry of 20 calendar days, see section 7(1) of the Act, from the day after\n submission of notification to the candidates concerned of the identity of the successful\n tenderer where the notification is accompanied by an explanation of the grounds for\n the decision in accordance with section 2(1), para (1) of the Act and section 171(2)\n of the Danish Public Procurement Act. In other situations, complaints of award procedures,\n see section 7(2) of the Act, must be lodged with the Danish Complaints Board for Public\n Procurement before the expiry of: 45 calendar days after the contracting entity has\n published a notice in the Official Journal of the European Union that the contracting\n entity has entered into a contract. The deadline is calculated from the day after\n the day when the notice was published. Not later than at the time of lodging a complaint\n with the Danish Complaints Board for Public Procurement, the complainant must notify\n the contracting entity in writing that a complaint has been lodged with the Danish\n Complaints Board for Public Procurement and whether the complaint was lodged during\n the standstill period, see section 6(4) of the Act. In cases where the complaint was\n not lodged within the standstill period, the complainant must furthermore indicate\n whether a suspensory effect of the complaint has been requested, see section 12(1)\n of the Act. The e-mail address of the Complaints Board for Public Procurement is klfu@naevneneshus.dk.\n The Complaints Board’s own complaints procedure is available at https://naevneneshus.dk/start-din-klage/klagenaevnet-for-udbud/vejledning/.
\n
\n
5.1.15 Techniques
Framework agreement:
No framework agreement
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for Udbud
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
TED eSender: Mercell Holding ASA
\n
\n
\n
\n
6 Results
Value of all contracts awarded in this notice: 1 Danish krone
\n
6.1 Result lot ldentifier: LOT-0000
At least one winner was chosen.
\n
6.1.2 Information about winners
Winner:
Official name: Seqirus UK Limited
\n
Tender:
\n
Tender identifier: Advance purchase agreement - Seqirus UK Limited
\n
Identifier of lot or group of lots: LOT-0000
\n
Subcontracting: Yes
\n
Subcontracting value is known: no
\n
Subcontracting percentage is known: no
\n
Description: Seqirus Vaccines Limited, Seqirus BV, Seqirus srl and Rovi Contract Manufacturing\n S.L.
\n
Contract information:
Identifier of the contract: Advance Purchase Agreement - Seqirus UK Limited
\n
Date of the conclusion of the contract: 16-10-2024
\n
The contract is awarded within a framework agreement: no
\n
\n
\n
\n
6.1.4 Statistical information
Received tenders or requests to participate:
Type of received submissions: Tenders
Number of tenders or requests to participate received: 1
\n
\n
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
\n
\n
Type of received submissions: Tenders from micro, small or medium tenderers
Number of tenders or requests to participate received: 0
\n
\n
Type of received submissions: Tenders from tenderers registered in other European Economic Area countries than the country of the buyer
Number of tenders or requests to participate received: 0
\n
\n
Type of received submissions: Tenders from tenders registered in countries outside of the European Economic Area
Number of tenders or requests to participate received: 1
\n
\n
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: Statens Serum Institut
\n
Registration number: 46 83 74 28
\n
Postal address: Artillerivej 5  
\n
Town: København S
\n
Postcode: 2300
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Email: nea@ssi.dk
\n
Telephone: +4532683978
\n
Internet address: https://www.ssi.dk
\n
Buyer profile: https://eu.eu-supply.com/ctm/company/companyinformation/index/281426
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0002
Official name: Klagenævnet for Udbud
\n
Registration number: 37795526
\n
Postal address: Nævnenes Hus, Toldboden 2  
\n
Town: Viborg
\n
Postcode: 8800
\n
Country subdivision (NUTS): Vestjylland (DK041)
\n
Country: Denmark
\n
Email: klfu@naevneneshus.dk
\n
Telephone: +45 72405600
\n
Internet address: https://klfu.naevneneshus.dk/
\n
Roles of this organisation:
Review organisation
\n
\n
\n
8.1 ORG-0003
Official name: Konkurrence- og Forbrugerstyrelsen
\n
Registration number: 10294819
\n
Postal address: Carl Jacobsens Vej 35  
\n
Town: Valby
\n
Postcode: 2500
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Email: kfst@kfst.dk
\n
Telephone: +45 41715000
\n
Internet address: http://www.kfst.dk
\n
Roles of this organisation:
Organisation providing more information on the review procedures
\n
\n
\n
8.1 ORG-0004
Official name: Seqirus UK Limited
\n
Registration number: GB685546196
\n
Postal address: Point, 29 Market Street  
\n
Town: Maidenhead
\n
Postcode: SL6 8AA
\n
Country subdivision (NUTS): Berkshire (UKJ11)
\n
Country: United Kingdom
\n
Email: adam.lewington1@seqirus.com
\n
Telephone: +44 (0)7584 388775
\n
Internet address: https://www.csl.com/wearecsl/ourbusinessesandproducts/cslseqirus
\n
Roles of this organisation:
Tenderer
\n
Winner of these lots: LOT-0000
\n
\n
\n
8.1 ORG-0005
Official name: Mercell Holding ASA
\n
Registration number: 980921565
\n
Postal address: Askekroken 11  
\n
Town: Oslo
\n
Postcode: 0277
\n
Country subdivision (NUTS): Oslo (NO081)
\n
Country: Norway
\n
Contact point: eSender
\n
Email: publication@mercell.com
\n
Telephone: +47 21018800
\n
Fax: +47 21018801
\n
Internet address: http://mercell.com/
\n
Roles of this organisation:
TED eSender
\n
\n
\n
\n
11 Notice information
11.1 Notice information
Notice identifier/version: d65e9eb6-e0a7-4316-97cf-db427c503ba0 - 01
\n
Form type: Result
\n
Notice type: Contract or concession award notice – standard regime
\n
Notice dispatch date: 14-11-2024 16:32 +00:00
\n
Notice dispatch date (eSender): 14-11-2024 17:00 +00:00
\n
Languages in which this notice is officially available: English 
\n
\n
11.2 Publication information
Notice publication number: 00699614-2024
\n
OJ S issue number: 224/2024
\n
Publication date: 18-11-2024
\n
\n
\n \n","opsummeringDA":{"card":{"titel":"Advance purchase agreement for the reservation and supply of pandemic influenza vaccine","ordregiver":"Statens Serum Institut","ordregiverId":"46837428 ","ordregiverIdDatavasket":"46837428","publiceringsdato":"2024-11-18+01:00","cpvKode":"33651600","cpvTitel":"Vacciner","formulartype":"Resultater","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Statens Serum Institut"],"beskrivelse":"The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents.\n\nSSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents.\n\nHence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven).\n\nAll terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.","bkSubTypeKode":"29","bkSubType":"Bekendtgørelse om indgåede kontrakter – det generelle direktiv, standardordningen","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Danmark"],"udforelsesstedBy":["København S"],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"Advance purchase agreement for the reservation and supply of pandemic influenza vaccine","ordregiver":"Statens Serum Institut","ordregiverId":"46837428 ","ordregiverIdDatavasket":"46837428","publiceringsdato":"2024-11-18+01:00","cpvKode":"33651600","cpvTitel":"Vaccines","formulartype":"Result","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Statens Serum Institut"],"beskrivelse":"The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents.\n\nSSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents.\n\nHence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven).\n\nAll terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.","bkSubTypeKode":"29","bkSubType":"Contract award notice – general directive, standard regime","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK011"],"udforelsesstedSubLand":["Byen København"],"udforelsesstedLand":["Denmark"],"udforelsesstedBy":["København S"],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]}}